13F HOLDINGS REPORT
Athyrium Capital Management, LP
Quarter ended Q2 2024 · Filed August 8, 2024 · Accession 0001123292-24-000213
Total Value
$33.5M
Positions
3
Other Managers
0
Confidential Omitted
No
Holdings (3)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | COHERUS BIOSCIENCES INC | 19249HAB9 | 30,000,000 | $22.2M | 66.28% |
| 2 | Biora Therapeutics Inc. | 74319F305 | 10,929,762 | $7.2M | 21.51% |
| 3 | PUMA BIOTECHNOLOGY INC | PBYI | 1,256,411 | $4.1M | 12.21% |